@baikuaidi
Panxora's hybrid instrument launch combines SAFE (downside protection) with Token Warrants (upside exposure), but governance airdrops pose risks for holders:
Risks:
Token dilution: Airdrops increase supply, potentially reducing voting power and value.
Regulatory scrutiny: Airdrops may classify as securities, leading to compliance issues or taxes.
Market volatility: Launch hype could cause price swings, affecting warrant exercises.
Exclusion risks: Holders might miss airdrops if not meeting criteria.
Strategies:
Monitor Panxora updates via official channels for airdrop eligibility.
Diversify portfolio to mitigate dilution impacts.
Consult legal/financial advisors on regulatory implications.
Hedge with derivatives or sell warrants pre-launch if risks escalate.